ReviewCurrent treatment options in oncology2024

Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review.

Chiara Benvenuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.